Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

  FDsys > More Information
(Search string is required)
 

78 FR 55263 - Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Availability


Download Files

Metadata

Document in Context
This is part of Federal Register Volume 78, Issue 175 (September 10, 2013)
View Entire Issue